BRPI0713062A2 - composição farmacêutica compreendendo tetraidrolipstatina - Google Patents

composição farmacêutica compreendendo tetraidrolipstatina Download PDF

Info

Publication number
BRPI0713062A2
BRPI0713062A2 BRPI0713062-7A BRPI0713062A BRPI0713062A2 BR PI0713062 A2 BRPI0713062 A2 BR PI0713062A2 BR PI0713062 A BRPI0713062 A BR PI0713062A BR PI0713062 A2 BRPI0713062 A2 BR PI0713062A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
tetrahydrolipstatin
carrageenan
pellets
optionally
Prior art date
Application number
BRPI0713062-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Tijana Stanic Ljubin
Tanja Rozman Peterka
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Publication of BRPI0713062A2 publication Critical patent/BRPI0713062A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0713062-7A 2006-06-27 2007-06-25 composição farmacêutica compreendendo tetraidrolipstatina BRPI0713062A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06013188.5 2006-06-27
EP06013188A EP1872777A1 (fr) 2006-06-27 2006-06-27 Composition pharmaceutique contenant de la tetrahydrolipstatin
PCT/EP2007/005598 WO2008000420A1 (fr) 2006-06-27 2007-06-25 Composition pharmaceutique comprenant de la tétrahydrolipstatine

Publications (1)

Publication Number Publication Date
BRPI0713062A2 true BRPI0713062A2 (pt) 2012-04-10

Family

ID=37142317

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0713062-7A BRPI0713062A2 (pt) 2006-06-27 2007-06-25 composição farmacêutica compreendendo tetraidrolipstatina

Country Status (7)

Country Link
EP (2) EP1872777A1 (fr)
AT (1) ATE471712T1 (fr)
BR (1) BRPI0713062A2 (fr)
CA (1) CA2656069A1 (fr)
DE (1) DE602007007320D1 (fr)
SI (1) SI2023901T1 (fr)
WO (1) WO2008000420A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101833250B1 (ko) 2010-10-25 2018-03-02 한미사이언스 주식회사 저융점 활성 성분을 포함하는 구형 압출과립, 이를 포함하는 경구 투여용 정제 및 이의 제조 방법
EP3233066B1 (fr) 2014-12-17 2021-11-10 Empros Pharma AB Composition à libération modifiée d'orlistat et d'acarbose pour le traitement de l'obésité

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
AU8184601A (en) * 2000-06-27 2002-01-08 Hoffmann La Roche Method for preparing a composition
US20030027786A1 (en) * 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition

Also Published As

Publication number Publication date
EP1872777A1 (fr) 2008-01-02
ATE471712T1 (de) 2010-07-15
EP2023901B1 (fr) 2010-06-23
DE602007007320D1 (de) 2010-08-05
WO2008000420A1 (fr) 2008-01-03
SI2023901T1 (sl) 2011-02-28
CA2656069A1 (fr) 2008-01-03
EP2023901A1 (fr) 2009-02-18

Similar Documents

Publication Publication Date Title
EP2817000B1 (fr) Compositions pharmaceutiques orales de dabigatran étexilate
DK2538925T3 (en) Apixabanformuleringer
JP4171091B2 (ja) 錠剤組成物
RU2465916C2 (ru) Твердый фармацевтический препарат матричного типа
EA022168B1 (ru) Способ получения уплотненного промежуточного продукта дималеата bibw 2992 и твердые таблетки, полученные из такого продукта
TWI660746B (zh) 一種替格瑞洛固體分散體及其製備方法
AU2014225449B2 (en) Stabilization of moisture-sensitive drugs
KR102072618B1 (ko) 서방성 토피라메이트 캡슐
WO2009039157A2 (fr) Formulations pharmaceutiques d'orlistat
BRPI0708191A2 (pt) " composições farmacêuticas de fluvastatina sódica "
Krueger et al. “MCC SANAQ® burst”—a new type of cellulose and its suitability to prepare fast disintegrating pellets
EP2533766A2 (fr) Mini-pastilles pharmaceutiques destinées à la libération prolongée d'acétate de flécaïnide
KR101421330B1 (ko) 붕괴정
BRPI0713062A2 (pt) composição farmacêutica compreendendo tetraidrolipstatina
KR100267525B1 (ko) 시타라빈 옥포스페이트 경질 캡슐제
CN113456639B (zh) 一种抗心律失常的药物组合物及制备方法
CN112057429B (zh) 雷西纳德控释药物组合物
JP2013047258A (ja) 腸溶性固体分散体を含んでなる固形製剤
JP2010001242A (ja) レバミピド固形製剤及びその製造方法
JPH08283146A (ja) 成形され、圧縮された徐放性単位投薬形態の調製法およびこうして得られた圧縮単位投薬形態
JP2676305B2 (ja) シタラビンオクホスファート硬カプセル剤
KR20240055103A (ko) 벰페도산의 약학 조성물
Al-Hashimi Engineering of multiparticulate systems to modify the drug release across orally disintegrating tablets
CA3232832A1 (fr) Composition pharmaceutique et son procede de preparation
WO2024043843A1 (fr) Compositions pharmaceutiques comprenant du cdca en tant que principe actif et excipients pertinents

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2256 DE 01/04/2014.